Skip to main content

Advertisement

SpringerLink
Log in

Stem cell therapy for stress urinary incontinence: a systematic review in human subjects

  • Review
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To systematically evaluate the current evidence on the safety and efficacy of stem cell therapy (SCT) in stress urinary incontinence (SUI) to allow objective comparison with existing surgical techniques.

Methods

Systematic literature search of Medline from years 1946–2012 using terms: “stem”, “cell”, “stress”, “urinary”, and “incontinence”. Included studies presented empirical data on the treatment of SUI using SCT. Outcomes: adverse events, incontinence, quality of life, urodynamic, transurethral ultrasound and urethral EMG findings.

Results

Eight studies met inclusion criteria (seven observational and one randomized). Quality score: median 10.75 of 20 (range 2–12.5). Adverse events: one patient had bladder perforation and two procedures could not be completed due to pain. Temporary urinary retention and cystitis were also reported. Incontinence score: Four studies describe significant improvement. Quality of life: significant improvement in four studies. Urodynamic outcomes: four studies show significant improvement in contractility of urethral sphincter; three studies demonstrate no change in bladder capacity and significant reduction in residual volume; significant improvement in urinary flow three studies, although two found no difference; increase in leak point pressure and detrusor pressure in three studies. Urethral ultrasound: three studies found significant increases in rhabdosphincter thickness and contractility. Urethral EMG: two studies found significant increases in the EMG at rest and at contraction.

Conclusion

Data suggest that SC treatment for SUI is safe and effective in the short term. However, the quality and maturity of the data are limited. Robust data from better quality studies comparing this to current surgical techniques are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Norton P, Brubaker L (2006) Urinary incontinence in women. Lancet 367(9504):57–67

    Article  PubMed  Google Scholar 

  2. Turner DA, Shaw C, McGrother CW (2004) The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK. BJU Int 93(9):1246–1252

    Article  PubMed  CAS  Google Scholar 

  3. Magon N, Kalra B, Malik S, Chauhan M (2011) Stress urinary incontinence: what, when, why, and then what? J midlife health 2(2):57–64

    PubMed  Google Scholar 

  4. NICE full guideline. http://www.nice.org.uk/nicemedia/live/10996/30281/30281.pdf

  5. Atala A (2008) Regenerative medicine and tissue engineering in urology. Nat Clin Pract Urol 5(11):621–631

    Article  PubMed  Google Scholar 

  6. Staack A, Rodriguez LV (2011) Stem cells for the treatment of urinary incontinence. Curr Urol Rep 12(1):41–46

    Article  PubMed  Google Scholar 

  7. Wang HJ, Chuang YC, Chancellor MB (2011) Development of cellular therapy for the treatment of stress urinary incontinence. Int Urogynecol J 22(9):1075–1083

    Article  PubMed  CAS  Google Scholar 

  8. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J (2003) Stem cells. Setting standards for human embryonic stem cells. Science 300(5621):913–916

    Article  PubMed  CAS  Google Scholar 

  9. Lo B, Zettler P, Cedars MI et al (2005) A new era in the ethics of human embryonic stem cell research. Stem Cells 23(10):1454–1459

    Article  PubMed  Google Scholar 

  10. Corcos J, Loutochin O, Campeau L et al (2011) Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourol Urodyn 30(3):447–455. doi:10.1002/nau.20998. Epub 2010 Nov 2

    Article  PubMed  Google Scholar 

  11. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142(5):1257–1267

    Article  PubMed  CAS  Google Scholar 

  12. Lee JY, Paik SY, Yuk SH, Lee JH, Ghil SH, Lee SS (2004) Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves. Mol Cells 18(3):309–313

    PubMed  CAS  Google Scholar 

  13. Rodríguez LV, Alfonso Z, Zhang R, Leung J, Wu B, Ignarro LJ (2006) Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 103(32):12167–12172

    Article  PubMed  Google Scholar 

  14. Zuk PA, Zhu M, Mizuno H et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2):211–228

    Article  PubMed  CAS  Google Scholar 

  15. Zhao W, Zhang C, Jin C et al (2011) Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. Eur Urol 59(1):155–163

    Article  PubMed  CAS  Google Scholar 

  16. McGuckin C, Jurga M, Ali H, Strbad M, Forraz N (2008) Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro. Nat Protoc 3(6):1046–1055

    Article  PubMed  CAS  Google Scholar 

  17. Lim JJ, Jang JB, Kim JY, Moon SH, Lee CN, Lee KJ (2010) Human umbilical cord blood mononuclear cell transplantation in rats with intrinsic sphincter deficiency. J Korean Med Sci 25(5):663–670

    Article  PubMed  Google Scholar 

  18. Liu L, Rando T (2011) Manifestations and mechanisms of stem cell aging. J Cell Biol 193(2):257–266

    Article  PubMed  CAS  Google Scholar 

  19. Gopinath SD, Rando TA (2008) Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell 7(4):590–598 Epub 2008 Jun 28

    Article  PubMed  CAS  Google Scholar 

  20. Kinebuchi Y, Aizawa N, Imamura T, Ishizuka O, Igawa Y, Nishizawa O (2010) Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter. Int J Urol 17(4):359–368 Epub 2010 Feb 25

    Article  PubMed  Google Scholar 

  21. Lamb B, Brown K, Nagpal K, Vincent C, Green JSA, Sevdalis N (2011) Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol 18:2116–2125

    Article  PubMed  Google Scholar 

  22. Blaganje M, Lukanović A (2012) Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence. Int J Gynaecol Obstet 117(2):164–167

    Article  PubMed  Google Scholar 

  23. Surcel C, Savu C, Chibelean C, Iordache A, Mirvald C, Sinescu I (2012) Comparative analysis of different surgical procedures for female stress urinary incontinence. Is stem cell implantation the future? Rom J Morphol Embryol 53(1):151–154

    PubMed  CAS  Google Scholar 

  24. Strasser H, Marksteiner R, Margreiter E, Pinggera GM, Mitterberger M, Frauscher F, Ulmer H, Fussenegger M, Kofler K, Bartsch G (2007) Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomized controlled trial. Lancet 369(9580):2179–2186

    Article  PubMed  CAS  Google Scholar 

  25. Strasser H, Marksteiner R, Margreiter E, Mitterberger M, Pinggera GM, Frauscher F, Fussenegger M, Kofler K, Bartsch G (2007) Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J Urol 25(4):385–392

    Article  PubMed  CAS  Google Scholar 

  26. Yamamoto T, Gotoh M, Hattori R, Toriyama K, Kamei Y, Iwaguro H, Matsukawa Y, Funahashi Y (2010) Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases. Int J Urol 17(1):75–82

    Article  PubMed  Google Scholar 

  27. Sèbe P, Doucet C, Cornu JN, Ciofu C, Costa P, de Medina SG, Pinset C, Haab F (2011) Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J 22(2):183–189 Epub 2010 Sep 7

    Article  PubMed  Google Scholar 

  28. Lee CN, Jang JB, Kim JY, Koh C, Baek JY, Lee KJ (2010) Human cord blood stem cell therapy for treatment of stress urinary incontinence. J Korean Med Sci 25(6):813–816 Epub 2010 May 24

    Article  PubMed  Google Scholar 

  29. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, Erickson J, Huard J, Chancellor MB (2008) 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19(6):881–883

    Article  PubMed  CAS  Google Scholar 

  30. Mitterberger M, Marksteiner R, Margreiter E, Pinggera GM, Frauscher F, Ulmer H, Fussenegger M, Bartsch G, Strasser H (2008) Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year followup of 63 patients. J Urol 179(1):226–231

    Article  PubMed  Google Scholar 

  31. Mitterberger M, Pinggera GM, Marksteiner R, Margreiter E, Fussenegger M, Frauscher F, Ulmer H, Hering S, Bartsch G, Strasser H (2008) Adult stem cell therapy of female stress urinary incontinence. Eur Urol 53(1):169–175

    Article  PubMed  Google Scholar 

  32. Mitterberger M, Marksteiner R, Margreiter E, Pinggera GM, Colleselli D, Frauscher F, Ulmer H, Fussenegger M, Bartsch G, Strasser H (2007) Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients. BJU Int 100(5):1081–1085

    PubMed  Google Scholar 

  33. Davila GW (2011) Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability. Adv Urol 2011:176498

    Article  PubMed  Google Scholar 

  34. Bump RC, Voss S, Beardsworth A, Manning M, Zhao YD, Chen W (2008) Long-term efficacy of duloxetine in women with stress urinary incontinence. BJU Int 102(2):214–218

    Article  PubMed  CAS  Google Scholar 

  35. Rogers RG (2008) Clinical practice. Urinary stress incontinence in women. N Engl J Med 358(10):1029–1036

    Article  PubMed  CAS  Google Scholar 

  36. Davila GW (2011) Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability. Adv Urol 2011:176498

    Article  PubMed  Google Scholar 

  37. Ward KL, Hilton P, UK and Ireland TVT Trial Group (2004) A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol 190(2):324–331

    Article  PubMed  Google Scholar 

  38. Silva-Filho AL, Cândido EB, Noronha A, Triginelli SA (2006) Comparative study of autologous pubovaginal sling and synthetic transobturator (TOT) SAFYRE sling in the treatment of stress urinary incontinence. Arch Gynecol Obstet 273(5):288–292

    Article  PubMed  CAS  Google Scholar 

  39. Monga AK, Robinson D, Stanton SL (1995) Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up. Br J Urol 76(2):156–160

    Article  PubMed  CAS  Google Scholar 

  40. Ogah J, Cody JD, Rogerson L (2009) Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 7(4):CD006375

    Google Scholar 

  41. Imamura M, Abrams P, Bain C et al (2010) Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess 14(40):1–188 iii–iv

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, Barnet and Chase Farm Hospital NHS Trust, Middlesex, UK

    M. Aref-Adib

  2. Department of Urology, Barnet and Chase Farm Hospital NHS Trust, Middlesex, UK

    B. W. Lamb

  3. Royal Free and University College Hospital School of Medicine, London, UK

    H. B. Lee, E. Akinnawo, M. M. A. Raza, A. Hughes, V. S. Mehta & R. I. Odonde

  4. Department of Obstetrics and Gynaecology, The North Middlesex University Hospital NHS Trust, London, UK

    W. Yoong

Authors
  1. M. Aref-Adib
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. W. Lamb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. B. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Akinnawo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. M. A. Raza
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. S. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. I. Odonde
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Yoong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Yoong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aref-Adib, M., Lamb, B.W., Lee, H.B. et al. Stem cell therapy for stress urinary incontinence: a systematic review in human subjects. Arch Gynecol Obstet 288, 1213–1221 (2013). https://doi.org/10.1007/s00404-013-3028-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-3028-0

Keywords

Search

Navigation